{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:27:35Z","timestamp":1772782055429,"version":"3.50.1"},"reference-count":120,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/s1359-6446(05)03622-6","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:22:50Z","timestamp":1130484170000},"page":"1503-1519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":557,"title":["Keynote review: Phosphodiesterase-4 as a therapeutic target"],"prefix":"10.1016","volume":"10","author":[{"given":"Miles D.","family":"Houslay","sequence":"first","affiliation":[]},{"given":"Peter","family":"Schafer","sequence":"additional","affiliation":[]},{"given":"Kam Y.J.","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1359-6446(05)03622-6_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0026-895X(24)23096-0","article-title":"Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling","volume":"58","author":"Houslay","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research-still expanding after half a century","volume":"3","author":"Beavo","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00021.2003","article-title":"Localized effects of cAMP mediated by distinct routes of protein kinase A","volume":"84","author":"Tasken","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/S1359-6446(05)03622-6_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/mol.64.3.533","article-title":"Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system","volume":"64","author":"Maurice","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib5","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","article-title":"Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling","volume":"278","author":"Conti","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/S1359-6446(05)03622-6_bib7","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1016\/j.febslet.2005.03.089","article-title":"Compartmentalization of phosphodiesterases and protein kinase A: opposites attract","volume":"579","author":"Baillie","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/S1359-6446(05)03622-6_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ceb.2005.01.003","article-title":"Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes","volume":"17","author":"Baillie","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.RES.0000134629.84732.11","article-title":"Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases","volume":"95","author":"Mongillo","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/S1359-6446(05)03622-6_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/med.20020","article-title":"Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors","volume":"25","author":"Castro","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/S1359-6446(05)03622-6_bib11","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.4049\/jimmunol.173.12.7531","article-title":"Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation","volume":"173","author":"Ariga","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib12","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib13","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1073\/pnas.96.21.11998","article-title":"Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice","volume":"96","author":"Jin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1096\/fj.03-0274com","article-title":"PDE4D plays a critical role in the control of airway smooth muscle contraction","volume":"17","author":"Mehats","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/S1359-6446(05)03622-6_bib15","first-page":"587","article-title":"Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme","volume":"27","author":"Zhang","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S1359-6446(05)03622-6_bib16","unstructured":"Lynch, M.J. et al. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterases interacting with ?-arrestin to control switching of the ?2-adrenergic receptor to activation of ERK in HEK293 cells. J. Biol. Chem. (in press)"},{"key":"10.1016\/S1359-6446(05)03622-6_bib17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cellsig.2005.04.003","article-title":"In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region","volume":"17","author":"McCahill","year":"2005","journal-title":"Cell. Signal."},{"key":"10.1016\/S1359-6446(05)03622-6_bib18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tips.2004.06.008","article-title":"PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease","volume":"25","author":"Banner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(05)03622-6_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.103.059097","article-title":"Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-gly oxylic acid amide (AWD 12-281), in human cell preparations","volume":"308","author":"Draheim","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(05)03622-6_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2004.09.027","article-title":"Phosphodiesterase 4-selective inhibition: novel therapy for the inflammation of COPD","volume":"18","author":"Jeffery","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/S1359-6446(05)03622-6_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","article-title":"Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)","volume":"25","author":"O'Donnell","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(05)03622-6_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/1568010043343822","article-title":"The potential of PDE4 inhibitors in respiratory disease","volume":"3","author":"Spina","year":"2004","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/S1359-6446(05)03622-6_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2920677","article-title":"Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram","volume":"292","author":"Shakur","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/S1359-6446(05)03622-6_bib24","doi-asserted-by":"crossref","first-page":"35980","DOI":"10.1074\/jbc.M204832200","article-title":"Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter","volume":"277","author":"Le Jeune","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0026-895X(24)12557-6","article-title":"Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic AMP-specific phosphodiesterase PDE4A10","volume":"59","author":"Rena","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib26","first-page":"839","article-title":"Characterization of an intronic promoter of a cyclic adenosine 3?,5?-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility","volume":"11","author":"Vicini","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib27","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/mol.104.009423","article-title":"Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene","volume":"67","author":"Wallace","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib28","doi-asserted-by":"crossref","first-page":"26615","DOI":"10.1074\/jbc.M001634200","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjp.0704743","article-title":"Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)","volume":"136","author":"MacKenzie","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib30","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1074\/jbc.271.28.16526","article-title":"Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation","volume":"271","author":"Sette","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib31","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1074\/jbc.275.15.10831","article-title":"Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation","volume":"275","author":"Oki","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0703636","article-title":"Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases","volume":"131","author":"Baillie","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/emboj\/18.4.893","article-title":"The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579","volume":"18","author":"Hoffmann","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/S1359-6446(05)03622-6_bib34","first-page":"16609","article-title":"ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases","volume":"275","author":"MacKenzie","year":"2000","journal-title":"The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjp.0705770","article-title":"Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells","volume":"142","author":"Shepherd","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib36","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.npp.1300440","article-title":"Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus","volume":"29","author":"Zhang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S1359-6446(05)03622-6_bib37","doi-asserted-by":"crossref","first-page":"33351","DOI":"10.1074\/jbc.M303269200","article-title":"Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2","volume":"278","author":"Bolger","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib38","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1074\/jbc.M006546200","article-title":"Myomegalin is a novel protein of the golgi\/centrosome that interacts with a cyclic nucleotide phosphodiesterase","volume":"276","author":"Verde","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib39","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1074\/jbc.275.14.10349","article-title":"UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions","volume":"275","author":"Beard","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib40","doi-asserted-by":"crossref","first-page":"30338","DOI":"10.1074\/jbc.M312687200","article-title":"The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases","volume":"279","author":"Richter","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0898-6568(96)00173-8","article-title":"Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases","volume":"9","author":"Souness","year":"1997","journal-title":"Cell. Signal."},{"key":"10.1016\/S1359-6446(05)03622-6_bib42","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1021\/bi992432w","article-title":"Conformational difference between PDE4 apoenzyme and holoenzyme","volume":"39","author":"Laliberte","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/S1359-6446(05)03622-6_bib43","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1021\/bi010096p","article-title":"Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors","volume":"40","author":"Liu","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/S1359-6446(05)03622-6_bib44","doi-asserted-by":"crossref","first-page":"31334","DOI":"10.1074\/jbc.271.49.31334","article-title":"The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram","volume":"271","author":"Huston","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj3470571","article-title":"Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells","volume":"347","author":"MacKenzie","year":"2000","journal-title":"J Biochem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib46","doi-asserted-by":"crossref","first-page":"11796","DOI":"10.1074\/jbc.274.17.11796","article-title":"Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition","volume":"274","author":"McPhee","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0026-895X(25)10513-0","article-title":"Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3","volume":"48","author":"Alvarez","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj3330139","article-title":"cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model","volume":"333","author":"Hoffmann","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/S1359-6446(05)03622-6_bib49","doi-asserted-by":"crossref","first-page":"14250","DOI":"10.1021\/bi971112e","article-title":"Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities","volume":"36","author":"Rocque","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/S1359-6446(05)03622-6_bib50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0898-6568(01)00167-X","article-title":"Identification of a surface on the beta-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5","volume":"13","author":"Steele","year":"2001","journal-title":"Cell. Signal."},{"key":"10.1016\/S1359-6446(05)03622-6_bib51","doi-asserted-by":"crossref","first-page":"14909","DOI":"10.1074\/jbc.274.21.14909","article-title":"The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform","volume":"274","author":"Yarwood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(02)03396-3","article-title":"Crystal structure of phosphodiesterase 4D and inhibitor complex","volume":"530","author":"Lee","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/S1359-6446(05)03622-6_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nbt1059","article-title":"A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design","volume":"23","author":"Card","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib54","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/S1359-6446(05)03622-6_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jmb.2004.01.040","article-title":"Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with amp 8-br-AMP, and rolipram","volume":"337","author":"Xu","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.105.083519","article-title":"Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors","volume":"314","author":"Liu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(05)03622-6_bib57","doi-asserted-by":"crossref","first-page":"28298","DOI":"10.1074\/jbc.M108353200","article-title":"TAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid","volume":"277","author":"Baillie","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib58","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1073\/pnas.262787199","article-title":"beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi","volume":"100","author":"Baillie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib59","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1074683","article-title":"Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins","volume":"298","author":"Perry","year":"2002","journal-title":"Science"},{"key":"10.1016\/S1359-6446(05)03622-6_bib60","doi-asserted-by":"crossref","first-page":"21999","DOI":"10.1074\/jbc.C000911200","article-title":"Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area","volume":"276","author":"Tasken","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib61","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/emboj\/20.8.1921","article-title":"mAKAP assembles a protein kinase A\/PDE4 phosphodiesterase cAMP signaling module","volume":"20","author":"Dodge","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/S1359-6446(05)03622-6_bib62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0898-6568(01)00264-9","article-title":"In addition to the SH3 binding region, multiple regions within the N-terminal noncatalytic portion of the cAMP-specific phosphodiesterase, PDE4A5, contribute to its intracellular targeting","volume":"14","author":"Beard","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/S1359-6446(05)03622-6_bib63","doi-asserted-by":"crossref","first-page":"28063","DOI":"10.1074\/jbc.M906144199","article-title":"The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3 Consequences for altered intracellular distribution","volume":"275","author":"Huston","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib64","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1073\/pnas.0405263102","article-title":"Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes","volume":"102","author":"Xiang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib65","doi-asserted-by":"crossref","first-page":"49230","DOI":"10.1074\/jbc.M303772200","article-title":"The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestins","volume":"278","author":"Bolger","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib66","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.4049\/jimmunol.173.8.4847","article-title":"TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling","volume":"173","author":"Abrahamsen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib67","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0898-6568(03)00092-5","article-title":"Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process","volume":"15","author":"Terry","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/S1359-6446(05)03622-6_bib68","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.288.5472.1822","article-title":"Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity","volume":"288","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/S1359-6446(05)03622-6_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2004.07.005","article-title":"A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases","volume":"15","author":"Zhang","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/S1359-6446(05)03622-6_bib70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0969-2126(03)00123-0","article-title":"Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity","volume":"11","author":"Huai","year":"2003","journal-title":"Structure (Camb)"},{"key":"10.1016\/S1359-6446(05)03622-6_bib71","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0026-895X(25)10862-6","article-title":"4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3?,5?-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain","volume":"12","author":"Schwabe","year":"1976","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(05)17708-3","article-title":"Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease","volume":"365","author":"Lipworth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1359-6446(05)03622-6_bib73","doi-asserted-by":"crossref","first-page":"13095","DOI":"10.1074\/jbc.M311556200","article-title":"Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity","volume":"279","author":"Huai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib74","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0026-895X(25)10530-0","article-title":"Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase","volume":"48","author":"Seldon","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(05)03622-6_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","article-title":"Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production","volume":"63","author":"Eigler","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib77","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1074\/jbc.271.34.20828","article-title":"Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells","volume":"271","author":"Ollivier","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib78","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1046\/j.1432-1033.2002.03157.x","article-title":"Inhibition of the NF-kappaB transcriptional activity by protein kinase A","volume":"269","author":"Takahashi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib79","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1074\/jbc.M207448200","article-title":"cAMP-induced Interleukin-10 promoter activation depends on CCAAT\/enhancer-binding protein expression and monocytic differentiation","volume":"278","author":"Brenner","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib80","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H","article-title":"Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells","volume":"29","author":"Platzer","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2567.2000.00082.x","article-title":"Calcitonin gene-related peptide inhibits lipopolysaccharide-induced interleukin-12 release from mouse peritoneal macrophages, mediated by the cAMP pathway","volume":"101","author":"Liu","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/S1359-6446(05)03622-6_bib82","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.162.4.2016","article-title":"Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation","volume":"162","author":"Baroja","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib83","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.4049\/jimmunol.153.8.3408","article-title":"Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors","volume":"153","author":"Essayan","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","article-title":"Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis","volume":"107","author":"Hanifin","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib85","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2004.025692","article-title":"Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells","volume":"60","author":"Mata","year":"2005","journal-title":"Thorax"},{"issue":"suppl 1","key":"10.1016\/S1359-6446(05)03622-6_bib86","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1152\/physrev.1999.79.1.S215","article-title":"Role of CFTR in airway disease","volume":"79","author":"Pilewski","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/S1359-6446(05)03622-6_bib87","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1074\/jbc.M407521200","article-title":"Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium","volume":"280","author":"Barnes","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib88","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1073\/pnas.0135434100","article-title":"A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin\/radixin\/moesin-binding phosphoprotein 50 is regulated by PKA","volume":"100","author":"Naren","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib89","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.1074\/jbc.275.19.14360","article-title":"Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin","volume":"275","author":"Sun","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib90","doi-asserted-by":"crossref","first-page":"29539","DOI":"10.1074\/jbc.M004961200","article-title":"E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells","volume":"275","author":"Sun","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib91","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V99.9.3390","article-title":"Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1\/CIP1) proteins in human acute lymphoblastic leukemia cells","volume":"99","author":"Ogawa","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S1359-6446(05)03622-6_bib92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02737806","article-title":"Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts","volume":"28","author":"Marko","year":"1998","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/S1359-6446(05)03622-6_bib93","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1160\/TH03-12-0768","article-title":"Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4","volume":"92","author":"Favot","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/S1359-6446(05)03622-6_bib94","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bjp.0701833","article-title":"Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4","volume":"124","author":"Blease","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.104.004853","article-title":"Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis","volume":"67","author":"Netherton","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib96","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1242\/jcs.01096","article-title":"PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration","volume":"117","author":"Fleming","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/S1359-6446(05)03622-6_bib97","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1182\/blood-2004-01-0240","article-title":"The phosphodiesterase PDE4B limits cAMP-associated PI3K\/AKT-dependent apoptosis in diffuse large B-cell lymphoma","volume":"105","author":"Smith","year":"2005","journal-title":"Blood"},{"key":"10.1016\/S1359-6446(05)03622-6_bib98","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0898-6568(01)00217-0","article-title":"The novel long PDE4A10 cyclic AMP phosphodiesterase shows a pattern of expression within brain that is distinct from the long PDE4A5 and short PDE4A1 isoforms","volume":"13","author":"McPhee","year":"2001","journal-title":"Cell. Signal"},{"key":"10.1016\/S1359-6446(05)03622-6_bib99","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","article-title":"Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect","volume":"407","author":"Cherry","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jnr.490410204","article-title":"Brain distribution of four rat homologues of the Drosophila dunce cAMP phosphodiesterase","volume":"41","author":"Engels","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S1359-6446(05)03622-6_bib101","first-page":"349","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography","volume":"20","author":"Perez-Torres","year":"2000","journal-title":"Comparison with monkey and rat brain. J. Chem. Neuroanat."},{"key":"10.1016\/S1359-6446(05)03622-6_bib102","first-page":"34","article-title":"The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges","volume":"5","author":"Renau","year":"2004","journal-title":"Curr. Opin. Investig. Drugs."},{"key":"10.1016\/S1359-6446(05)03622-6_bib103","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-2007-1017435","article-title":"Results of a phase II study of the antidepressant effect of rolipram","volume":"17","author":"Zeller","year":"1984","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/S1359-6446(05)03622-6_bib104","first-page":"563","article-title":"Rolipram in Parkinson's disease","volume":"40","author":"Parkes","year":"1984","journal-title":"Adv. Neurol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib105","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1073\/pnas.0402595101","article-title":"The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery","volume":"101","author":"Nikulina","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib106","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"suppl","key":"10.1016\/S1359-6446(05)03622-6_bib107","first-page":"217","article-title":"Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP+","volume":"46","author":"Hulley","year":"1995","journal-title":"J. Neural Transm."},{"key":"10.1016\/S1359-6446(05)03622-6_bib108","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1460-9568.1995.tb01041.x","article-title":"Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo","volume":"7","author":"Hulley","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/S1359-6446(05)03622-6_bib109","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1073\/pnas.97.12.6751","article-title":"Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D","volume":"97","author":"Hansen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(05)03622-6_bib110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0026-895X(24)23155-2","article-title":"Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes","volume":"55","author":"Ma","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0026-895X(24)26397-5","article-title":"Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils","volume":"56","author":"Wang","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib112","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib113","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1152\/ajplung.00384.2003","article-title":"Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers","volume":"287","author":"Barber","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib114","unstructured":"Houslay, M.D. The long and short of vascular smooth muscle phosphodiesterase-4 as a putative therapeutic target. Mol. Pharmacol. (in press)"},{"key":"10.1016\/S1359-6446(05)03622-6_bib115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/mol.105.014126","article-title":"Vascular smooth muscle cell phenotype-dependent phosphodiesterase 4D short form expression: role of differential histone acetylation on cAMP-regulated function","volume":"68","author":"Tilley","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib116","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2005.04.023","article-title":"Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions","volume":"116","author":"van Schalkwyk","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib117","first-page":"747","article-title":"Gateways to clinical trials","volume":"25","author":"Bayes","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/S1359-6446(05)03622-6_bib118","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(99)01335-6","article-title":"The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains.","volume":"460","author":"Beard","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/S1359-6446(05)03622-6_bib119","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2091-3-24","article-title":"Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5","volume":"3","author":"Bolger","year":"2002","journal-title":"BMC Biochem."},{"key":"10.1016\/S1359-6446(05)03622-6_bib120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J. Clin. Invest."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644605036226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644605036226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:55:38Z","timestamp":1761220538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644605036226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":120,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1359644605036226"],"URL":"https:\/\/doi.org\/10.1016\/s1359-6446(05)03622-6","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keynote review: Phosphodiesterase-4 as a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1359-6446(05)03622-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}